Last reviewed · How we verify
NCT06160479: HypoCal
The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital
NA trial testing Calcium supplement in Hypocalcemia in Pregnancy in 444 participants. Status unknown.
12 September 2023
Quick facts
| Lead sponsor | Siriraj Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 444 |
| Start date | 5 May 2022 |
| Primary completion | 12 September 2023 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Calcium supplement
Conditions studied
- Hypocalcemia in Pregnancy — all drugs for Hypocalcemia in Pregnancy →
Sponsor
Siriraj Hospital
Who can join
18 and older, female only, with Hypocalcemia in Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Calcium is an essential element for fundamental physiological functions and during pregnancy. However, higher calcium intake can induce constipation, flatulence, nausea, or kidney stones. This study aims to evaluate the incidence of hypocalcemia among pregnant women in the first half of pregnancy in Thailand. Also, Comparison of calcium level in pregnant women in the third trimester who received and not received calcium during pregnancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06160479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium supplement
Trials testing the same drug.
- NCT07364279 — Effect of Wii Fit Balance Board Games on Balance in Patients With Osteoporosis Post Mastectomy · NA · completed
- NCT03452696 — Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate · Phase 3 · completed
- NCT03133195 — The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA · Phase 3 · completed
- NCT02822378 — Dried Plums and Bone Health in Postmenopausal Women · NA · active not recruiting
- NCT00729183 — Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall · Phase 3 · completed
Other Siriraj Hospital trials
Trials by the same sponsor.
- NCT07262034 — The Impact of Preoperative Nutrition Intervention on Muscle Mass Preserve in Older Adults Undergoing Elective Surgery · not yet recruiting
- NCT07402486 — A Phase II Prospective Study of Maastro Applicator Brachytherapy for Rectal Cancer · Phase 2 · not yet recruiting
- NCT07298577 — Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ult · NA · not yet recruiting
- NCT07239908 — Resuscitation Enhancement to Avoid Rearrest Through Evidence-based Strategies in Prehospital Post-resuscitation Care · Phase 2, PHASE3 · not yet recruiting
- NCT07110961 — The Suggested Immobilization Test With Exploratory Heart Rate Variability Analysis for Diagnosis of Restless Legs Syndro · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06160479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Siriraj Hospital
- Last refreshed: 7 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06160479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing